How have OVB shares performed in 2024?

Ovoca Bio's stock was trading at GBX 0.90 on January 1st, 2024. Since then, OVB shares have decreased by 27.8% and is now trading at GBX 0.65. View the best growth stocks for 2024 here .

What other stocks do shareholders of Ovoca Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ovoca Bio investors own include CarMax (KMX) , Beazer Homes USA (BZH) , Chesapeake Lodging Trust (CHSP) , Mitie Group (MTO) , New World Development (NDVLY) , Parsley Energy (PE) , Bilibili (BILI) , Bango (BGO) , Belmont Resources (BEA) and BioDelivery Sciences International (BDSI) .

How do I buy shares of Ovoca Bio?

Shares of OVB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:OVB

Ovoca Bio (OVB) Share Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free OVB Stock Alerts

GBX 0.65

-0.07 (-9.72%)

(As of 04/19/2024 ET)

Compare

Today's Range: 0.61
▼
0.69
50-Day Range: 0.55
▼
0.99
52-Week Range: 0.45
▼
14.80

Volume: 377,404 shs
Average Volume: 225,773 shs
Market Capitalization: £530,140.00

P/E Ratio: N/A
Dividend Yield: 0.83%
Price Target: N/A

Stock Analysis Chart Competitors

Get Ovoca Bio alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Ovoca Bio

Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for women health. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.

OVB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OVB Stock News Headlines

August 2, 2022 | finance.yahoo.com

Ovoca Bio plc (OVB.L)

February 25, 2022 | reuters.com

OVB.I - Ovoca Bio PLC Profile | Reuters

See More Headlines

Receive OVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ovoca Bio and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:OVB
CUSIP: N/A
CIK: N/A
Web: www.ovocabio.com
Phone: 353 1 661 9819
Fax: N/A
Employees: 5
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-2,330,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -33.98%
Return on Assets: -4.89%

Debt

Debt-to-Equity Ratio: 4.80
Current Ratio: 3.70
Quick Ratio: 1.77

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: GBX 0.69 per share
Price / Cash Flow: 1.00
Book Value: GBX 6 per share
Price / Book: 0.12

Miscellaneous

Outstanding Shares: 81,560,000
Free Float: N/A
Market Cap: £562,764.00
Optionable: Not Optionable
Beta: 0.68

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Kirill Andreyevich Golovanov (Age 46)
Interim Chairman of the Board & CEO
Comp: $125.07k
Mr. Dmitriy Nikitashenko
Vice President of Finance
Reneta Nikolova
Corporate Secretary

Key Competitors

View All Competitors

OVB Stock Analysis - Frequently Asked Questions

How have OVB shares performed in 2024?: Ovoca Bio's stock was trading at GBX 0.90 on January 1st, 2024. Since then, OVB shares have decreased by 27.8% and is now trading at GBX 0.65.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Ovoca Bio own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Ovoca Bio investors own include CarMax (KMX), Beazer Homes USA (BZH), Chesapeake Lodging Trust (CHSP), Mitie Group (MTO), New World Development (NDVLY), Parsley Energy (PE), Bilibili (BILI), Bango (BGO), Belmont Resources (BEA) and BioDelivery Sciences International (BDSI).
How do I buy shares of Ovoca Bio?: Shares of OVB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:OVB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial